Median salary
$102,753
per year · annualized USD
Typical range
$70.4k – $125k
25th–75th percentile
Disclosing pay
78.6%
33 of 42 roles
Live roles
42
open right now
Specialized Tax Services - Research & Development Tax - Senior Associate
Clinical Research Associate, Sponsor Dedicated
Large-Scale Integrated Photonics Lab Research Associate Intern
Senior Clinical Research Associate - CNS/Rare Disease (US, Central))
Senior Clinical Research Associate - CNS / Rare Disease (US, Central)
Senior Clinical Research Associate - CNS / Rare Disease (US, Central)
Senior Clinical Research Associate - Oncology (West Coast)
Research Associate - Vice President
| Company | Median | Roles |
|---|---|---|
| CS Colorado State University | $64,395 | 8 |
| WC Worldwide Clinical Trials | $145,000 | 4 |
ICON plc
|
$113,544 | 4 |
Agilent Technologies
|
$109,983 | 3 |
Colorado School of Mines
|
$125,000 | 2 |
| FO Fortrea | $117,500 | 2 |
KBI Biopharma
|
$70,000 | 2 |
| MS Morgan Stanley | $147,500 | 1 |
See every Biotech Research role
Browse the live listings, or save this search and get alerted the moment a new one posts.
The median salary for Biotech Research roles in Colorado is $102,753 per year. Most pay falls between $70,375 (25th percentile) and $125,000 (75th percentile), with the broader 10th–90th percentile band running from $62,464 to $145,000.
These figures are computed live from 42 active Biotech Research roles in Colorado on JobsRadar, of which 33 (78.6%) publish a salary range. Pay is normalized to annualized USD so roles can be compared on equal terms; the highest-paying roles listed above show their original posted currency. Numbers refresh every few hours as new roles are posted and older ones close.
Employers currently hiring well-paid Biotech Research roles in Colorado include PwC, IQVIA, Hewlett Packard Enterprise and Worldwide Clinical Trials.
Salary transparency varies by employer and region, so the disclosing share above reflects only roles that publish pay — not every open position. Use it as a directional benchmark rather than an exact offer.